{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:01:04Z","timestamp":1777982464840,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22214MFDS251"],"award-info":[{"award-number":["22214MFDS251"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22214MFDS251"],"award-info":[{"award-number":["22214MFDS251"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22214MFDS251"],"award-info":[{"award-number":["22214MFDS251"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22214MFDS251"],"award-info":[{"award-number":["22214MFDS251"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07026-7","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:27:28Z","timestamp":1775107648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discriminative stimulus, rewarding, and reinforcing effects of 4-Fluoroethylphenidate in rodents"],"prefix":"10.1007","author":[{"given":"Min Gyeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Kyu","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Son Seung","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Keun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Kyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"7026_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","volume":"71","author":"SM Aarde","year":"2013","unstructured":"Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA (2013) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130\u2013140","journal-title":"Neuropharmacology"},{"key":"7026_CR2","unstructured":"Addiction EMCfDaD (2020) New psychoactive substances: global perspective"},{"key":"7026_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s002130000569","volume":"153","author":"MT Bardo","year":"2000","unstructured":"Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31\u201343","journal-title":"Psychopharmacology"},{"key":"7026_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/164_2018_178","volume":"252","author":"MH Baumann","year":"2018","unstructured":"Baumann MH, Walters HM, Niello M, Sitte HH (2018) Neuropharmacology of synthetic cathinones. Handb Exp Pharmacol 252:113\u2013142","journal-title":"Handb Exp Pharmacol"},{"key":"7026_CR5","first-page":"3","volume":"23","author":"J Carlier","year":"2019","unstructured":"Carlier J, Giorgetti R, Vari MR, Pirani F, Ricci G, Busardo FP (2019) Use of cognitive enhancers: methylphenidate and analogs. Eur Rev Med Pharmacol Sci 23:3\u201315","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7026_CR6","doi-asserted-by":"crossref","unstructured":"Colpaert FC (1987) Drug Discrimination: Methods of Manipulation, Measurement, and Analysis. In: Bozarth MA (ed) Methods of Assessing the Reinforcing Properties of Abused Drugs. Springer New York, New York, NY, pp 341\u2013372","DOI":"10.1007\/978-1-4612-4812-5_17"},{"key":"7026_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0091-3057(99)00047-7","volume":"64","author":"FC Colpaert","year":"1999","unstructured":"Colpaert FC (1999) Drug discrimination in neurobiology. Pharmacol Biochem Behav 64:337\u2013345","journal-title":"Pharmacol Biochem Behav"},{"key":"7026_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/19253621221142480","volume":"12","author":"JM Corkery","year":"2022","unstructured":"Corkery JM, Schifano F (2022) First death involving 4-Fluoroethylphenidate (4F-EPH): case report, user experiences, and review of the related literature. Acad Forensic Pathol 12:149\u2013166","journal-title":"Acad Forensic Pathol"},{"key":"7026_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1021\/jm950697c","volume":"39","author":"HM Deutsch","year":"1996","unstructured":"Deutsch HM, Shi Q, Gruszecka-Kowalik E, Schweri MM (1996) Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs. J Med Chem 39:1201\u20131209","journal-title":"J Med Chem"},{"key":"7026_CR10","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852925100357","volume":"30","author":"S Dodd","year":"2025","unstructured":"Dodd S, Ospina-Pinillos L, Markowitz JS (2025) Central nervous system stimulants in recreational and medical use. CNS Spectr 30:e52","journal-title":"CNS Spectr"},{"key":"7026_CR11","unstructured":"EMA (2006) Guideline on the non-clinical investigation of the dependence potential of medicinal products"},{"key":"7026_CR12","unstructured":"FDA (2017) Guidance for industry: assessment of abuse potential of drugs. U.S. Department of Health and Human Services"},{"key":"7026_CR13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00213-017-4562-4","volume":"234","author":"MB Gatch","year":"2017","unstructured":"Gatch MB, Dolan SB, Forster MJ (2017) Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats. Psychopharmacology 234:1237\u20131245","journal-title":"Psychopharmacology"},{"key":"7026_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12987","volume":"26","author":"MB Gatch","year":"2021","unstructured":"Gatch MB, Shetty RA, Sumien N, Forster MJ (2021) Behavioral effects of four novel synthetic cathinone analogs in rodents. Addict Biol 26:e12987","journal-title":"Addict Biol"},{"key":"7026_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0269881113482532","volume":"27","author":"DJ Heal","year":"2013","unstructured":"Heal DJ, Smith SL, Gosden J, Nutt DJ (2013) Amphetamine, past and present\u2013a pharmacological and clinical perspective. J Psychopharmacol 27:479\u2013496","journal-title":"J Psychopharmacol"},{"key":"7026_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuropharm.2018.01.049","volume":"142","author":"DJ Heal","year":"2018","unstructured":"Heal DJ, Gosden J, Smith SL (2018) Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans. Neuropharmacology 142:89\u2013115","journal-title":"Neuropharmacology"},{"key":"7026_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/02698811251330780","volume":"39","author":"DJ Heal","year":"2025","unstructured":"Heal DJ, Smith SL, Gosden J, Rowlett J (2025) Discriminating evidence - use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs. J Psychopharmacol 39:629\u2013651","journal-title":"J Psychopharmacol"},{"key":"7026_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2024.173848","volume":"244","author":"S Huang","year":"2024","unstructured":"Huang S, Riley AL (2024) Drug discrimination learning: interoceptive stimulus control of behavior and its implications for regulated and dysregulated drug intake. Pharmacol Biochem Behav 244:173848","journal-title":"Pharmacol Biochem Behav"},{"key":"7026_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0014-2999(85)90615-6","volume":"117","author":"MG Kolta","year":"1985","unstructured":"Kolta MG, Shreve P, Uretsky NJ (1985) Effect of methylphenidate pretreatment on the behavioral and biochemical responses to amphetamine. Eur J Pharmacol 117:279\u2013282","journal-title":"Eur J Pharmacol"},{"key":"7026_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2019.00262","volume":"13","author":"BN Kuhn","year":"2019","unstructured":"Kuhn BN, Kalivas PW, Bobadilla AC (2019) Understanding addiction using animal models. Front Behav Neurosci 13:262","journal-title":"Front Behav Neurosci"},{"key":"7026_CR21","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1089\/cap.2013.0074","volume":"23","author":"JS Markowitz","year":"2013","unstructured":"Markowitz JS, Zhu HJ, Patrick KS (2013) Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability. J Child Adolesc Psychopharmacol 23:648\u2013654","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"7026_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","volume":"87","author":"JA Marusich","year":"2014","unstructured":"Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH (2014) Pharmacology of novel synthetic stimulants structurally related to the bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206\u2013213","journal-title":"Neuropharmacology"},{"key":"7026_CR23","doi-asserted-by":"crossref","unstructured":"McGovern R, Luderman L, Knecht K, Griffin WC 3rd (2014) Influence of sensitization on the discriminative stimulus effects of methylphenidate in mice. Behav Pharmacol 25:766\u2013774","DOI":"10.1097\/FBP.0000000000000095"},{"key":"7026_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/dta.2167","volume":"9","author":"G McLaughlin","year":"2017","unstructured":"McLaughlin G, Morris N, Kavanagh PV, Power JD, Dowling G, Twamley B, O\u2019Brien J, Hessman G, Murphy B, Walther D, Partilla JS, Baumann MH, Brandt SD (2017) Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (+\/-)-threo and (+\/-)-erythro diastereomers. Drug Test Anal 9:347\u2013357","journal-title":"Drug Test Anal"},{"key":"7026_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1124\/jpet.114.214288","volume":"350","author":"T Mori","year":"2014","unstructured":"Mori T, Uzawa N, Kazawa H, Watanabe H, Mochizuki A, Shibasaki M, Yoshizawa K, Higashiyama K, Suzuki T (2014) Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats. J Pharmacol Exp Ther 350:403\u2013411","journal-title":"J Pharmacol Exp Ther"},{"key":"7026_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00862","volume":"11","author":"EK Nagy","year":"2020","unstructured":"Nagy EK, Overby PF, Olive MF (2020) Reinforcing effects of the synthetic cathinone alpha-Pyrrolidinopropiophenone (alpha-PPP) in a repeated extended access binge paradigm. Front Psychiatry 11:862","journal-title":"Front Psychiatry"},{"key":"7026_CR27","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.neubiorev.2010.10.012","volume":"35","author":"EC O\u2019Connor","year":"2011","unstructured":"O\u2019Connor EC, Chapman K, Butler P, Mead AN (2011) The predictive validity of the rat self-administration model for abuse liability. Neurosci Biobehav Rev 35:912\u2013938","journal-title":"Neurosci Biobehav Rev"},{"key":"7026_CR28","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1111\/j.1360-0443.2007.02011.x","volume":"102","author":"LV Panlilio","year":"2007","unstructured":"Panlilio LV, Goldberg SR (2007) Self-administration of drugs in animals and humans as a model and an investigative tool. Addiction 102:1863\u20131870","journal-title":"Addiction"},{"key":"7026_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/jps.2600500611","volume":"50","author":"PS Portoghese","year":"1961","unstructured":"Portoghese PS, Malspeis L (1961) Relative hydrolytic rates of certain alkyl (b) dl-alpha-(2-piperidyl)-phenylacetates. J Pharm Sci 50:494\u2013501","journal-title":"J Pharm Sci"},{"key":"7026_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00124","volume":"13","author":"MT Robins","year":"2019","unstructured":"Robins MT, Blaine AT, Ha JE, Brewster AL, van Rijn RM (2019) Repeated use of the psychoactive substance Ethylphenidate impacts neurochemistry and reward learning in adolescent male and female mice. Front Neurosci 13:124","journal-title":"Front Neurosci"},{"key":"7026_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1586\/17512433.2016.1167597","volume":"9","author":"F Schifano","year":"2016","unstructured":"Schifano F, Papanti GD, Orsolini L, Corkery JM (2016) Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. Expert Rev Clin Pharmacol 9:943\u2013954","journal-title":"Expert Rev Clin Pharmacol"},{"key":"7026_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1124\/jpet.301.2.527","volume":"301","author":"MM Schweri","year":"2002","unstructured":"Schweri MM, Deutsch HM, Massey AT, Holtzman SG (2002) Biochemical and behavioral characterization of novel methylphenidate analogs. J Pharmacol Exp Ther 301:527\u2013535","journal-title":"J Pharmacol Exp Ther"},{"key":"7026_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0022-3565(24)36838-7","volume":"282","author":"DS Segal","year":"1997","unstructured":"Segal DS, Kuczenski R (1997) Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J Pharmacol Exp Ther 282:561\u2013573","journal-title":"J Pharmacol Exp Ther"},{"key":"7026_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/0269881118822111","volume":"33","author":"SL Smith","year":"2019","unstructured":"Smith SL, Dean RL, Todtenkopf MS, Heal DJ (2019) Investigation of the reinforcing potential of Samidorphan and Naltrexone by fixed and progressive ratio intravenous self-administration testing in heroin-maintained rats. J Psychopharmacol 33:383\u2013391","journal-title":"J Psychopharmacol"},{"key":"7026_CR35","doi-asserted-by":"publisher","unstructured":"Somkuwar SS, Darna M, Kantak KM, Dwoskin LP (2013) Adolescence methylphenidate treatment in a rodent model of attention deficit\/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood. Biochem Pharmacol 86:309\u2013316. https:\/\/doi.org\/10.1016\/j.bcp.2013.04.013","DOI":"10.1016\/j.bcp.2013.04.013"},{"key":"7026_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s007260070051","volume":"19","author":"TM Tzschentke","year":"2000","unstructured":"Tzschentke TM (2000) The medial prefrontal cortex as a part of the brain reward system. Amino Acids 19:211\u2013219","journal-title":"Amino Acids"},{"key":"7026_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","volume":"12","author":"TM Tzschentke","year":"2007","unstructured":"Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227\u2013462","journal-title":"Addict Biol"},{"key":"7026_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/FBP.0b013e3280143226","volume":"18","author":"RL Williard","year":"2007","unstructured":"Williard RL, Middaugh LD, Zhu HJ, Patrick KS (2007) Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity. Behav Pharmacol 18:39\u201351","journal-title":"Behav Pharmacol"},{"key":"7026_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00110","volume":"8","author":"JB Zawilska","year":"2017","unstructured":"Zawilska JB (2017) An expanding world of novel psychoactive substances: opioids. Front Psychiatry 8:110","journal-title":"Front Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07026-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:27:30Z","timestamp":1775107650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07026-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":39,"alternative-id":["7026"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07026-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7637489\/v1","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal care, maintenance, and experimental procedures were approved by the Animal Ethics Board of the National Institute of Food and Drug Safety Evaluation\/Ministry of Food and Drug Safety (approval number: MFDS-23-021-c2). Furthermore, animal care and experimental procedures were conducted in accordance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}